Even One Ventures Fund II LP
RaisingEmerging manager
Raising: Form D filed Feb 2026 reports an open-ended (indefinite) offering
- Vintage
- 2026
- Fund size
- $20M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
Starts biotechs that make scientific advances rapidly accessible to patients. Builds companies across oncology, immune, women's health, rare disease and longevity, including personalized cancer therapies, diagnostics and gene editing.Inferred from the firm's website and portfolio companies
02 · Initial check
$200K to $333K (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Jacob Stern, Manager of the General Partner of the Issuer
- José Mejía Oneto, General Partner
- Sytse Sijbrandij, Manager of the General Partner of the Issuer
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideEven One Ventures starts biotechs that make scientific advances rapidly accessible to patients.
Even One Ventures starts biotechs that make scientific advances rapidly accessible to patients.
https://evenone.ventures/
06 · Sources
Last verified: Oct 28, 2026